logo

For the Inventor, By the Inventor

Bothell, WA, United States of America

Sonus Pharmaceuticals, Inc.


USPTO Granted Patents = 32

% Expired Patents = 40.6


Forward Citations = 1,510

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal Steven C Quay (19 out of 94 patents)

silverMedal Manjari Lal (8 out of 8 patents)

bronzeMedal Panayiotis P Constantinides (7 out of 24 patents)

4.  Yuehua Zhang (7 out of 7 patents)

5.  Karel J Lambert (7 out of 7 patents)

6.  Nagesh Palepu (5 out of 5 patents)

7.  Lynn Gold (4 out of 6 patents)

8.  Alexander K Tustian (4 out of 5 patents)

9.  Andrew Leo (2 out of 2 patents)

10.  Dean R Kessler (2 out of 2 patents)

11.  Andrew M Nienstedt (1 out of 1 patent)

12.  Steven M Quay (1 out of 1 patent)

13.  Ronald A Roy (1 out of 1 patent)

14.  Dilip Worah (1 out of 1 patent)

15.  Lynn C Gold (0 patent)


Core Competencies:
Lipophilic Compounds
Platinum Compounds
Tocopherol Derivatives
Emulsion Vehicles
Ultrasound Contrast Media
Colloidal Dispersions
Fluorinated Compounds
Gaseous Media
Therapeutic Compositions
Carcinoma Treatment
Persistent Bubbles
Phase Shift Colloids

32 patents:

1. 7786164 - Lipophilic di(anticancer drug) compounds, compositions, and related methods (2010-08-31),
2. 7786134 - Lipophilic anticancer drug compounds, compositions and related methods (2010-08-31),
3. 7268245 - Multinuclear platinum compounds (2007-09-11),
4. 7232919 - Platinum compounds (2007-06-19),
5. 7223770 - Tocopherol-modified therapeutic drug compounds (2007-05-29),
6. 7129368 - Platinum carboxylate anticancer compounds (2006-10-31),
7. 7091374 - Fluorinated compounds (2006-08-15),
8. 7038071 - Platinum compounds (2006-05-02),
9. 7030155 - Emulsion vehicle for poorly soluble drugs (2006-04-18),
10. 6982282 - Emulsion vehicle for poorly soluble drugs (2006-01-03),
11. 6864386 - Fluorinated compounds (2005-03-08),
12. 6858227 - Vitamin E conjugates (2005-02-22),
13. 6727280 - Method for treating colorectal carcinoma using a taxane/tocopherol formulation (2004-04-27),
14. 6683194 - Tocopherol derivatives (2004-01-27),
15. 6667048 - Emulsion vehicle for poorly soluble drugs (2003-12-23),
Company Overview
Sonus Pharmaceuticals, Inc. is a biotechnology company based in Bothell, Washington, focused on developing innovative therapies for cancer and other serious diseases. The company specializes in the research and development of drug delivery systems and therapeutic agents that leverage advanced technologies to improve treatment efficacy and patient outcomes. With a commitment to addressing unmet medical needs, Sonus aims to bring transformative solutions to the healthcare landscape through its cutting-edge research initiatives.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

32 Patents

#15 in Bothell, WA

#225 in Washington

#10,599 in US

#20,671 in the World

Bothell, WA (US)
Bothell, WA, United States of America

Sonus Pharmaceuticals, Inc.

Forward Citations = 1,510

14 inventors:

goldMedal Steven C Quay (19 out of 94 patents)

silverMedal Manjari Lal (8 out of 8 patents)

bronzeMedal Panayiotis P Constantinides (7 out of 24 patents)

4.  Yuehua Zhang (7 out of 7 patents)

5.  Karel J Lambert (7 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sonus Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/sonus-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…